Dialysis-related systemic microinflammation is associated with specific genomic patterns.
暂无分享,去创建一个
F. Staal | L. Gesualdo | F. Schena | P. Pontrelli | G. Grandaliano | G. Zaza | S. Granata | G. Pertosa | M. Rossini | S. Porreca | Silvia Porreca
[1] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[2] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[3] P. Sakkinen,et al. Interleukin-6 exacerbates early atherosclerosis in mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[4] M. Klagsbrun,et al. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] N. Ueda,et al. Arachidonate 12-lipoxygenases. , 1997, Progress in lipid research.
[6] C. Wanner,et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] E. Elvevoll,et al. Cellular activation responses in blood in relation to lipid pattern: healthy men and women in families with myocardial infarction or cancer , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[8] J. Cornhill,et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.
[9] A. Lusis,et al. Genetic control of the inflammatory response induced by oxidized lipids. , 1995, The American journal of cardiology.
[10] A. Mallet,et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils , 1992, The Journal of experimental medicine.
[11] J. Reiber,et al. Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis: Observations in Individuals With a Hereditary Bleeding Tendency , 2001, Circulation.
[12] J. Wallace,et al. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. , 1990, The American journal of physiology.
[13] K. Tsuchiya,et al. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] B. Manns,et al. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] A. Wessel,et al. Interleukin-1 and related proteins in cardiovascular disease in adults and children. , 2001, Shock.
[16] J. Kastelein,et al. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. , 1999, Atherosclerosis.
[17] P. Libby,et al. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[18] W. Wahli,et al. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.... , 1995, Chemistry & biology.
[19] J. Slot,et al. Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets. , 1983, The Journal of clinical investigation.
[20] G. Gross,et al. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. , 2001, Analytical biochemistry.
[21] P. Groot,et al. Chemokines and atherosclerosis. , 1999, Atherosclerosis.
[22] M. Peters-Golden,et al. Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. , 1996, The Biochemical journal.
[23] C. Parker,et al. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes , 1983, The Journal of experimental medicine.
[24] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.
[25] J. Peschon,et al. Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55* , 1996, The Journal of Biological Chemistry.
[26] M. Territo,et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[27] Klaus Eichmann,et al. Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation , 1998, The Journal of experimental medicine.
[28] Peter Stenvinkel,et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.
[29] E. Rubin,et al. Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. , 1999, Circulation.
[30] G. Truskey,et al. The distribution of intimal white blood cells in the normal rabbit aorta. , 1995, Atherosclerosis.
[31] S. Matikainen,et al. Tyrosine kinase activity is involved in the protein kinase C induced expression ofinterleukin‐1β gene in monocytic cells , 1993, FEBS letters.
[32] R. Tracy. Epidemiological Evidence for Inflammation in Cardiovascular Disease , 1999, Thrombosis and Haemostasis.
[33] J. Berliner,et al. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086. , 1999, Circulation research.
[34] R. Shattock,et al. Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway. , 1996, The Journal of infectious diseases.
[35] H. Tilg,et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.
[36] Y. Yamaguchi,et al. Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver. , 1999, Transplantation.
[37] P. Kuna,et al. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. , 1992, Journal of immunology.
[38] David J. Anderson,et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 , 1992, Cell.
[39] T. Krakauer. Human interleukin 1. , 1986, Critical reviews in immunology.
[40] A. Waage,et al. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. , 1988, Immunology.
[41] M. Kowala,et al. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. , 2000, Atherosclerosis.
[42] D. Wagner,et al. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. , 2001, Blood.
[43] E. Leonard,et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.
[44] A. Chait,et al. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[45] R. Kroczek,et al. Activated Platelets Induce Tissue Factor Expression on Human Umbilical Vein Endothelial Cells by Ligation of CD40 , 1998, Thrombosis and Haemostasis.
[46] M. R. Roach,et al. Quantitative measurements of early atherosclerotic lesions on rabbit aortae from vascular casts. , 1989, Atherosclerosis.
[47] D. Steinberg,et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[48] Jianglin Fan,et al. Atherosclerosis and inflammation: Mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis , 1998 .
[49] W. Koenig,et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.
[50] C. Funk,et al. Disruption of 12/15-Lipoxygenase Expression in Peritoneal Macrophages , 1996, The Journal of Biological Chemistry.
[51] Qingbo Xu,et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.
[52] J. Berliner,et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.
[53] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .
[54] B. Spiegelman,et al. Peroxisome proliferator–activated receptor γ ligands and atherosclerosis: ending the heartache , 2000 .
[55] S. Amar,et al. Differentiation of Monocytes to Macrophages Primes Cells for Lipopolysaccharide Stimulation via Accumulation of Cytoplasmic Nuclear Factor κB , 1999, Infection and Immunity.
[56] S. Dower,et al. Acceleration of Human Neutrophil Apoptosis by TRAIL1 , 2003, The Journal of Immunology.
[57] T. Kita,et al. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis , 2001, Current opinion in lipidology.
[58] D. Wagner. Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.
[59] H. Maegawa,et al. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. , 1996, Metabolism: clinical and experimental.
[60] P. Libby,et al. Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque , 1995, Journal of cardiovascular pharmacology.
[61] M. Rola-Pleszczynski,et al. IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes. , 1994, Journal of immunology.
[62] H. Lehr,et al. Immunopathogenesis of Atherosclerosis: Endotoxin Accelerates Atherosclerosis in Rabbits on Hypercholesterolemic Diet , 2000, Circulation.
[63] D. Stewart. Impact of endothelin-1 on vascular structure and function. , 1998 .
[64] A. Tedgui,et al. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[65] V. Ord,et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[66] H. Eichler,et al. Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[67] M. Thivierge,et al. Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP. , 1993, The Journal of biological chemistry.
[68] I. Tatsuno,et al. Comparison of the effect between leukotriene B4 and leukotriene B5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes , 1990, Agents and Actions.
[69] G. FitzGerald,et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. , 1997, The Journal of clinical investigation.
[70] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[71] J. Cristol,et al. Imbalance of Oxidants and Antioxidants in Haemodialysis Patients , 1999, Blood Purification.
[72] M. Roederer,et al. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[73] C. Leslie,et al. The Role of Calcium and Phosphorylation of Cytosolic Phospholipase A2 in Regulating Arachidonic Acid Release in Macrophages* , 1998, The Journal of Biological Chemistry.
[74] C. Glass,et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .
[75] B. Samuelsson. The discovery of the leukotrienes. , 2000, American journal of respiratory and critical care medicine.
[76] K. Burnand,et al. Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low‐density lipoprotein and in atherosclerotic lesions , 1999, FEBS letters.
[77] B. Johansen,et al. Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions. , 2000, Circulation research.
[78] A. Minami,et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. , 2004, Arthritis and rheumatism.
[79] R. Bryant,et al. Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoids. , 1982, Biochemical pharmacology.
[80] J. W. Woods,et al. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. , 1995, The Journal of clinical investigation.
[81] Andrew C. Li,et al. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice , 2000 .
[82] B. Johansen,et al. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[83] R. DuBois,et al. Prostaglandin endoperoxide synthase: why two isoforms? , 1996, The American journal of physiology.
[84] N. Mukaida,et al. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. , 1998, Journal of immunology.
[85] W. Carter,et al. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin , 1989, The Journal of cell biology.
[86] W. Jaross,et al. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis. , 1999, Atherosclerosis.
[87] I. Issemann,et al. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. , 1993, Journal of molecular endocrinology.
[88] J. Morrow,et al. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. , 1992, The Journal of clinical investigation.
[89] S. Reddy,et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.
[90] R. Asmis,et al. Differential expression of CD14, CD36 and the LDL receptor on human monocyte-derived macrophages , 1998, Histochemistry and Cell Biology.
[91] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[92] Y. Kaneda,et al. Local Overexpression of Monocyte Chemoattractant Protein‐1 at Vessel Wall Induces Infiltration of Macrophages and Formation of Atherosclerotic Lesion: Synergism With Hypercholesterolemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[93] B. Osterud,et al. Role of monocytes in atherogenesis. , 2003, Physiological reviews.
[94] Z. Galis,et al. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. , 2002, The American journal of pathology.
[95] D. Praticò,et al. Oxygen free radicals and platelet activation. , 1997, Free radical biology & medicine.
[96] K. Ley,et al. RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium , 2001, Circulation.
[97] John I. Gallin,et al. Inflammation: Basic Principles and Clinical Correlates , 1992 .
[98] J. Pernow,et al. Endothelin in myocardial ischaemia and reperfusion. , 1997, Cardiovascular research.
[99] A. Herman,et al. Influence of hypercholesterolaemia on the reactivity of isolated rabbit arteries to 15-lipoxygenase metabolites of arachidonic acid: comparison with platelet-derived agents and vasodilators. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[100] F. Marks,et al. cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin. , 1998, Biochimica et biophysica acta.
[101] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[102] C. Holmes. Biocompatibility of Peritoneal Dialysis Solutions , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[103] S. Velleman,et al. Expression and localization of the proteoglycan decorin during the progression of cholesterol induced atherosclerosis in Japanese quail: implications for interaction with collagen type I and lipoproteins. , 1999, Atherosclerosis.
[104] T. Irimura,et al. Density‐dependent induction of TNF‐α release from human monocytes by immobilized P‐selectin , 2000 .
[105] E. Uhl,et al. Expression of mRNA for Phospholipase A2, Cyclooxygenases, and Lipoxygenases in Cultured Human Umbilical Vascular Endothelial and Smooth Muscle Cells and in Biopsies from Umbilical Arteries and Veins , 1998, Journal of Vascular Research.
[106] D. Alexander,et al. Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. , 2006, Kidney international.
[107] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[108] T. Harris,et al. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes. , 1991, Immunology.
[109] F. Ferro,et al. Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. , 2001, Immunology letters.
[110] P. Mannon,et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. , 1998, The Journal of clinical investigation.
[111] G. Winsor,et al. Interleukin-4 and IFN-gamma differentially stimulate macrophage chemoattractant protein-1 (MCP-1) and eotaxin production by intestinal epithelial cells. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[112] C. Mackay,et al. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[113] M. Morrissey,et al. Human monocytes respond to leukotriene B4 with a transient increase in cytosolic calcium. , 1993, Cellular immunology.
[114] B. Osterud. Platelet activating factor enhancement of lipopolysaccharide‐induced tissue factor activity in monocytes: requirement of platelets and granulocytes , 1992, Journal of leukocyte biology.
[115] N. Pawlowski,et al. The cyclooxygenase and lipoxygenase activities of platelet-depleted human monocytes. , 1984, The Journal of allergy and clinical immunology.
[116] T. Willson,et al. The nuclear receptor PPARγ - Bigger than fat , 1998 .
[117] Y. Fukuuchi,et al. Polymorphism in the Promoter of Lipopolysaccharide Receptor CD14 and Ischemic Cerebrovascular Disease , 2000, Stroke.
[118] T. Saito,et al. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[119] K. Williams,et al. The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[120] B. Ossterud. The high responder phenomenon: enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. , 1995, Platelets.
[121] U. Brunk,et al. OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. , 1998, Free radical research.
[122] K. Ley,et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. , 1999, Circulation research.
[123] L. D. Ward,et al. Interleukin‐6: Structure‐function relationships , 1997, Protein science : a publication of the Protein Society.
[124] B. Osterud,et al. Increased lipopolysaccharide‐induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2 , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[125] M. Namiki,et al. Interleukin-8 in chronic renal failure and dialysis patients. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[126] C. Glass,et al. Expression of the peroxisome proliferator-activated receptor � (PPAR�) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .
[127] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[128] G. Rangan,et al. Altered expression of nuclear factor-kappaB in peripheral blood mononuclear cells in chronic haemodialysis patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[129] M. S. Alhamdani,et al. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[130] U. Dianzani,et al. CD38 expression and functional activities are up‐regulated by IFN‐γ on human monocytes and monocytic cell lines , 2001, Journal of leukocyte biology.
[131] A. Daugherty,et al. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .
[132] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[133] M. Bureau,et al. Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.
[134] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.
[135] S. Sprang,et al. C2 domains from different Ca2+ signaling pathways display functional and mechanistic diversity. , 2001, Biochemistry.
[136] S. Reddy,et al. Analysis of the Secretory Phospholipase A2 That Mediates Prostaglandin Production in Mast Cells* , 1997, The Journal of Biological Chemistry.
[137] B. Dewald,et al. Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytes , 1995 .
[138] 清 斉藤,et al. 抗高脂血症薬フェノフィブラートの抗動脈硬化作用(I)コレステロール負荷ウサギにおける血清脂質低下作用を介さない抗動脈硬化作用 , 1995 .
[139] A. Daugherty,et al. Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor−/− Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[140] W. Wahli,et al. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. , 1996, Annual review of cell and developmental biology.
[141] Staal,et al. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[142] C. Hack,et al. Complement activation in patients with sepsis is in part mediated by C-reactive protein. , 1998, The Journal of infectious diseases.
[143] M. Baggiolini,et al. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.
[144] T. Kodama,et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[145] J. Strong,et al. Origin of atherosclerosis in childhood and adolescence. , 2000, The American journal of clinical nutrition.
[146] J. Bernhagen,et al. MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.
[147] J. Drazen,et al. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. , 1993, The Journal of clinical investigation.
[148] G. Schmitz,et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[149] D. Steinberg,et al. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[150] J. Vilček,et al. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. , 1987, Journal of immunology.
[151] W. Yang,et al. TGF‐β1 down‐regulates inflammatory cytokine‐induced VCAM‐1 expression in cultured human glomerular endothelial cells , 2000 .
[152] P. Libby,et al. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. , 1999, The Journal of clinical investigation.
[153] S. Haskill,et al. Signal transduction from the extracellular matrix , 1993, The Journal of cell biology.
[154] G. Bren,et al. Elimination of Senescent Neutrophils by TNF-Related Apoptosis-Inducing Ligand1 , 2005, The Journal of Immunology.
[155] P. Libby,et al. Cytokines Regulate Genes Involved in Atherogenesis a , 1994, Annals of the New York Academy of Sciences.
[156] P. Libby,et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. , 1998, Circulation research.
[157] W. Kübler,et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[158] G. Kaplan,et al. Arachidonic acid metabolism by human monocytes. Studies with platelet- depleted cultures , 1983, The Journal of experimental medicine.
[159] D. Steinberg,et al. Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.
[160] Y. Yazaki,et al. Expression of platelet-derived growth factor beta receptor on human monocyte-derived macrophages and effects of platelet-derived growth factor BB dimer on the cellular function. , 1993, The Journal of biological chemistry.
[161] S. Shapiro,et al. Proteinases secreted by human mononuclear phagocytes. , 1991, The Journal of rheumatology. Supplement.
[162] R. Philip,et al. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.
[163] A. Lusis,et al. Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.
[164] P. Edwards,et al. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[165] A. J. Valente,et al. Aortic intimal monocyte recruitment in the normo and hypercholesterolemic baboon (Papio cynocephalus) , 2004, Virchows Archiv A.
[166] P. Libby,et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.
[167] P. Ridker,et al. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[168] F. Parhami,et al. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. , 1993, The Journal of clinical investigation.
[169] J. Stankova,et al. Cytokines and eicosanoids regulate PAF receptor gene expression. , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.
[170] G. Tau,et al. Biologic functions of the IFN‐γ receptors , 1999, Allergy.
[171] D. Steinberg,et al. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.
[172] R. Dixon,et al. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. , 1990, The Journal of biological chemistry.
[173] K. Umesono,et al. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.
[174] L. Havekes,et al. Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[175] L. Nielsen,et al. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. , 1996, Atherosclerosis.
[176] J. Bernhagen,et al. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). , 2006, Atherosclerosis.
[177] W. Campbell,et al. Characterization of arachidonic acid metabolism in Watanabe heritable hyperlipidemic (WHHL) and New Zealand white (NZW) rabbit aortas. , 1988, Prostaglandins.
[178] D. Steinberg,et al. Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.
[179] William B. Smith,et al. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. , 1996, Journal of immunology.
[180] R. McEver. Selectins: Novel Receptors that Mediate Leukocyte Adhesion During Inflammation , 1991, Thrombosis and Haemostasis.
[181] E. Yeh,et al. Inhibition of α4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice , 1998 .
[182] B. Østerud,et al. Production of blood coagulation factory V and tissue thromboplastin by macrophages in vitro , 1981, FEBS letters.
[183] A. Douvdevani,et al. The Effect of Peritoneal Dialysis Fluid on the Release of Il-113 and Tnfa by Macrophages/Monocytes , 1993 .
[184] J. Berliner,et al. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.
[185] P. Halushka,et al. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. , 1994, The Journal of pharmacology and experimental therapeutics.
[186] J. Maclouf,et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. , 1999, The Journal of clinical investigation.
[187] T. Palkama. Induction of interleukin-1 production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line. , 1991, Immunology.
[188] William L. Smith,et al. Calcium-mediated Translocation of Cytosolic Phospholipase A2 to the Nuclear Envelope and Endoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.
[189] M. Cathcart,et al. Selective Inhibition of Cytosolic Phospholipase A2 in Activated Human Monocytes , 1997, The Journal of Biological Chemistry.
[190] H. Shindou,et al. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. , 2000, Biochemical and biophysical research communications.
[191] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[192] Yan Huang,et al. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[193] S. Onodera,et al. Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis* , 2000, The Journal of Biological Chemistry.
[194] A. Rigotti,et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[195] P. Brandtzaeg,et al. Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .
[196] R. Bryant,et al. Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. , 1980, The Journal of biological chemistry.
[197] J. Cooper,et al. Factor VIII, ABO blood group and the incidence of ischaemic heart disease , 1994, British journal of haematology.
[198] J Auwerx,et al. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. , 1996, Journal of lipid research.
[199] M. Rosenfeld. Leukocyte recruitment into developing atherosclerotic lesions: the complex interaction between multiple molecules keeps getting more complex. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[200] W. Wood,et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.
[201] P. Libby,et al. Cutting Edge: Heat Shock Protein (HSP) 60 Activates the Innate Immune Response: CD14 Is an Essential Receptor for HSP60 Activation of Mononuclear Cells1 , 2000, The Journal of Immunology.
[202] B. Østerud,et al. Macrophages produce blood coagulation factors , 1980, FEBS letters.
[203] J. Qiao,et al. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[204] S. Hazen,et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.
[205] T. Irimura,et al. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P‐selectin–sialyl Lewis X interaction , 1994, Journal of leukocyte biology.
[206] P. Peplow. Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.
[207] H. Asaoku,et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.
[208] R. Gerrity,et al. Suppression of Foam Cell Lesions in Hypercholesterolemic Rabbits by Inhibition of Thromboxane A2 Synthesis , 1988, Arteriosclerosis.
[209] G. Zimmerman,et al. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[210] A. Weyrich,et al. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. , 1995, The Journal of clinical investigation.
[211] G. Kaysen,et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[212] G. Sempowski,et al. Interleukin‐4 and interferon‐γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets , 1996, Journal of cellular physiology.
[213] T. Matsumura,et al. Cis-acting DNA Elements of Mouse Granulocyte/Macrophage Colony-stimulating Factor Gene Responsive to Oxidized Low Density Lipoprotein* , 1999, The Journal of Biological Chemistry.
[214] M. Reale,et al. Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl leukotriene D4: a role for mediation of interleukin 1. , 1995, Atherosclerosis.
[215] C. Dinarello,et al. Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. , 1988, Blood.
[216] H. Wieland,et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. , 1997, American journal of respiratory cell and molecular biology.
[217] R. Cohen,et al. 15‐Hydroxyeicosatetraenoic Acid and Diabetic Endothelial Dysfunction in Rabbit Aorta , 1995, Journal of cardiovascular pharmacology.
[218] D. Stengel,et al. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[219] A. Ford-hutchinson,et al. Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues , 1993, FEBS letters.
[220] P. Libby,et al. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. , 1999, The American journal of pathology.
[221] Z. Galis,et al. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[222] R. Leboeuf,et al. Loss of Lymphotoxin-α but Not Tumor Necrosis Factor-α Reduces Atherosclerosis in Mice* , 2002, The Journal of Biological Chemistry.
[223] R. Wykle,et al. 1-O-alkyl-linked phosphoglycerides of human platelets: Distribution of arachidonate and other acyl residues in the ether-linked and diacyl species , 1983, Lipids.
[224] J. H. Schwartz,et al. Identification of an 8-Lipoxygenase Pathway in Nervous Tissue of Aplysia californica * , 1997, The Journal of Biological Chemistry.
[225] M. Kamm,et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease , 1997, The Lancet.
[226] J. Qiao,et al. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. , 1994, The Journal of clinical investigation.
[227] M. Reidy,et al. Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. , 1986, The American journal of pathology.
[228] O. Griffith,et al. Biologic and pharmacologic regulation of mammalian glutathione synthesis. , 1999, Free radical biology & medicine.
[229] Yoshimasa Yamamoto,et al. Chlamydia pneumoniae Infection Induces Differentiation of Monocytes into Macrophages , 2002, Infection and Immunity.
[230] J. Qiao,et al. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[231] D. Steinberg,et al. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.
[232] B. S. Robinson,et al. Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin, and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives. , 1997, Circulation research.
[233] H. Tai,et al. Thromboxanes: synthase and receptors. , 1998, Journal of biomedical science.
[234] K. Mann,et al. Biochemistry and Physiology of Blood Coagulation , 1999, Thrombosis and Haemostasis.
[235] J. Morrow,et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[236] J. Naismith,et al. TNFα and the TNF receptor superfamily: Structure‐function relationship(s) , 2000, Microscopy research and technique.
[237] J. Harrison,et al. Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[238] G. Kaysen. The microinflammatory state in uremia: causes and potential consequences. , 2001, Journal of the American Society of Nephrology : JASN.
[239] A. Giles,et al. Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo , 1996, British journal of haematology.
[240] H. Mischak,et al. Haemodialysis, atherosclerosis and inflammation-identifying molecular mechanisms of chronic vascular disease in ESDR patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[241] L. Osnes,et al. Aspirin Potentiates LPS-induced Fibrin Formation (FPA) and TNF-α-synthesis in Whole Blood , 2000, Thrombosis and Haemostasis.
[242] J. Nilsson,et al. Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL , 1996 .
[243] M. Aviram,et al. Oxidized Low Density Lipoprotein: Atherogenic and Proinflammatory Characteristics during Macrophage Foam Cell Formation. An Inhibitory Role for Nutritional Antioxidants and Serum Paraoxonase , 1999, Clinical chemistry and laboratory medicine.
[244] E. Wayner,et al. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[245] L. Gesualdo,et al. Cytokines and bioincompatibility. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[246] B. Østerud,et al. Fibrinogen increases lipopolysaccharide-induced tumor necrosis factor-α and interleukin-8 release, and enhances tissue factor activity in monocytes in a modified whole blood system , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[247] S. Wahl,et al. Macrophage Production of TGF‐β and Regulation by TGF‐β , 1990 .
[248] A. Lusis,et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. , 1999, Circulation research.
[249] D. Tarng,et al. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. , 2002, Journal of the American Society of Nephrology : JASN.
[250] A. Christensson,et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. , 2001, Kidney international.
[251] Fred A. Wright,et al. Practical FDR-based sample size calculations in microarray experiments , 2005, Bioinform..
[252] L. Osnes,et al. Acetylsalicylic Acid and Sodium Salicylate Inhibit LPS-lnduced NF-kB/c-Rel Nuclear Translocation, and Synthesis of Tissue Factor (TF) and Tumor Necrosis Factor alfa (TNF-a) in Human Monocytes , 1996, Thrombosis and Haemostasis.
[253] A. Tall,et al. Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.
[254] B. Modrell,et al. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. , 1992, The Journal of biological chemistry.
[255] Yukiko Kurihara,et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.
[256] M. Suematsu,et al. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. , 1999, The Journal of clinical investigation.
[257] W. Stehbens,et al. The effect of hypercholesterolemia on aortic endothelium studied en face. , 1975, Atherosclerosis.
[258] D. Morel,et al. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. , 1990, Journal of immunology.
[259] L. Petit,et al. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[260] D. Schwenke,et al. Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[261] E. Schönherr,et al. Extracellular Matrix and Cytokines: A Functional Unit , 2000, Developmental immunology.
[262] S. Akira,et al. Interleukin-6 family of cytokines and gp130. , 1995, Blood.
[263] K. Zibara,et al. Modulation of Expression of Endothelial Intercellular Adhesion Molecule-1, Platelet–Endothelial Cell Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Aortic Arch Lesions of Apolipoprotein E–Deficient Compared With Wild-Type Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[264] B. Setty,et al. 13-Hydroxyoctadecadienoic acid (13-HODE) stimulates prostacyclin production by endothelial cells. , 1987, Biochemical and biophysical research communications.
[265] J. Filep,et al. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. , 1997, The Journal of clinical investigation.
[266] D. Steinberg,et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[267] T. Lint,et al. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. , 1976, Journal of immunology.
[268] M. Tykocinski,et al. Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. , 1998, Blood.
[269] S. Shak,et al. A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes. , 1983, The Journal of biological chemistry.
[270] M. Kostrzewa,et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[271] L. Jørgensen,et al. Platelet thrombosis and non-traumatic intimal injury in mouse aorta. , 1973, Thrombosis et diathesis haemorrhagica.
[272] M. Hemler,et al. The pathophysiologic role of alpha 4 integrins in vivo. , 1994, The Journal of clinical investigation.
[273] Takao Shimizu,et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.
[274] R. Cummings,et al. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells , 1992, The Journal of cell biology.
[275] W. Owen,et al. Role of bioincompatibility in dialysis morbidity and mortality. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[276] A. Bręborowicz. Free Radicals in Peritoneal Dialysis: Agents of Damage? , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[277] Z. Pan. Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes. , 1998, Biochimica et biophysica acta.
[278] D. Lefer,et al. Monocyte rolling in early atherogenesis: vital role in lesion development. , 1999, Circulation research.
[279] N. O. Solum,et al. Procoagulant expression in platelets and defects leading to clinical disorders. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[280] M. Sticherling,et al. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. , 1995, International archives of allergy and immunology.
[281] P. Libby,et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. , 1998, Circulation.
[282] C. Dinarello,et al. Induction of tumor necrosis factor during extracorporeal blood purification. , 1987, The New England journal of medicine.
[283] A. von Eckardstein,et al. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages , 2000, Journal of Molecular Medicine.
[284] M. Rola-Pleszczynski,et al. Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti-peptide antibody. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[285] G M Saidel,et al. Relative significance of endothelium and internal elastic lamina in regulating the entry of macromolecules into arteries in vivo. , 1994, Circulation research.
[286] Y. Snitko,et al. High specificity of human secretory class II phospholipase A2 for phosphatidic acid. , 1997, The Biochemical journal.
[287] A. Tedgui,et al. Anti-Inflammatory Mechanisms in the Vascular Wall , 2001, Circulation research.
[288] C. Wanner,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.
[289] T. van der Poll,et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees , 1994, The Journal of experimental medicine.
[290] T. Schall,et al. Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.
[291] M. Aepfelbacher,et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[292] S. Yamamoto,et al. "Enzymatic" lipid peroxidation: reactions of mammalian lipoxygenases. , 1991, Free radical biology & medicine.
[293] J. Otto,et al. Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2 (*) , 1995, The Journal of Biological Chemistry.
[294] S. Schwartz. The intima : A new soil. , 1999, Circulation research.
[295] Qingbo Xu,et al. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. , 2000, Circulation.
[296] M. Murakami,et al. Eicosanoid generation from antigen‐primed mast cells by extracellular mammalian 14‐kDa group II phospholipase A2 , 1991, FEBS letters.
[297] R. Ross,et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[298] R. Rothlein,et al. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. , 2000, Free radical biology & medicine.
[299] B. Descamps-Latscha,et al. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. , 1991, Kidney international.
[300] P. Libby,et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[301] F. Schena,et al. Inflammation and carnitine in hemodialysis patients. , 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[302] C. Power,et al. Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line (*) , 1995, The Journal of Biological Chemistry.
[303] J. Himmelfarb,et al. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. , 1997, Journal of the American Society of Nephrology : JASN.
[304] G. Bondjers,et al. Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. , 1987, Journal of lipid research.
[305] I. Rahman,et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. , 1998, The Journal of clinical investigation.
[306] J. Bluestone,et al. Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[307] K. Werdan,et al. The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system. , 1999, European cytokine network.
[308] Peters-Golden. Cell biology of the 5-lipoxygenase pathway , 1998, American journal of respiratory and critical care medicine.
[309] D. Steinberg,et al. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. , 1991, Journal of lipid research.
[310] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[311] A. Siegbahn,et al. Role of Platelet P-Selectin and CD40 Ligand in the Induction of Monocytic Tissue Factor Expression , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[312] K. Ley,et al. Molecular mechanisms of leukocyte recruitment in the inflammatory process. , 1996, Cardiovascular research.
[313] P. Libby,et al. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. , 1997, The Journal of clinical investigation.
[314] K. Umesono,et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[315] D H Blankenhorn,et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1992, Circulation.
[316] F. Mach. The role of chemokines in atherosclerosis , 2001, Current atherosclerosis reports.
[317] B. Okopień,et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. , 1998, International journal of clinical pharmacology and therapeutics.
[318] V. Hombach,et al. C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis , 2001, Circulation.
[319] D. Steinberg,et al. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[320] Lipsky Pe. Role of cyclooxygenase-1 and -2 in health and disease. , 1999 .
[321] M. Cybulsky,et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.
[322] E. Feskens,et al. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[323] R. Ulevitch,et al. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation , 1993, The Journal of experimental medicine.
[324] J. Cornhill,et al. The effect of the duration of cholesterol feeding on the development of sudanophilic lesions in the rabbit aorta. , 1976, Atherosclerosis.
[325] R. Kramer,et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. , 1988, Biochimica et biophysica acta.
[326] D. Steinberg,et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[327] M. Kasper,et al. Immunohistochemical localisation of a secretory group-II phosholipase A2 in human atherosclerotic plaques , 1995 .
[328] W. Parmley,et al. Aspirin inhibits platelet activity but does not attenuate experimental atherosclerosis. , 1993, American heart journal.
[329] L. Marshall,et al. Depletion of Human Monocyte 85-kDa Phospholipase A2 Does Not Alter Leukotriene Formation* , 1997, The Journal of Biological Chemistry.
[330] D. Shih,et al. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. , 2000, Circulation.
[331] L. Sower,et al. Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon‐induced cellular differentiation , 1998, Journal of cellular physiology.
[332] R. D. Dyer,et al. Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties , 1997, British journal of pharmacology.
[333] A. Weyrich,et al. Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.
[334] R. Young,et al. Stress proteins, infection, and immune surveillance , 1989, Cell.
[335] C. Benjamin,et al. Structure/function studies on vascular cell adhesion molecule-1. , 1992, The Journal of biological chemistry.
[336] M. Chonchol. HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Neutrophil Dysfunction and Infection Risk in End‐Stage Renal Disease , 2006, Seminars in dialysis.
[337] C. Schindler,et al. Lymphocytes are important in early atherosclerosis. , 2001, The Journal of clinical investigation.
[338] P. J. Newman,et al. The biology of PECAM-1. , 1997, The Journal of clinical investigation.
[339] A. Beaudet,et al. Absence of P-Selectin, but Not Intercellular Adhesion Molecule-1, Attenuates Neointimal Growth After Arterial Injury in Apolipoprotein E–Deficient Mice , 2001, Circulation.
[340] J. Vermylen,et al. atherosclerosis-prone sites in response to hypercholesterolemia Endothelial von Willebrand factor recruits platelets to , 2013 .
[341] J. Lehmann,et al. Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.
[342] K. Shimada,et al. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. , 2000, The American journal of cardiology.
[343] E. Stier,et al. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[344] T. Takano,et al. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.
[345] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[346] J. Knowles,et al. Genetic Modifiers of Atherosclerosis in Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[347] Shozo Yamamoto,et al. Mammalian lipoxygenases: molecular structures and functions. , 1992, Biochimica et biophysica acta.
[348] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[349] E. Rietschel,et al. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin , 1994, Medical Microbiology and Immunology.
[350] A. Stopeck,et al. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. , 1993, Journal of Biological Chemistry.
[351] B. Johansen,et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. , 1998, Journal of immunology.
[352] A. Ristimäki,et al. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. , 1994, The Journal of biological chemistry.
[353] M. Tsang,et al. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. , 1993, Journal of immunology.
[354] B. Furie,et al. The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction , 1999, Thrombosis and Haemostasis.
[355] R. Stocker,et al. Oxidation of Free Fatty Acids in Low Density Lipoprotein by 15-Lipoxygenase Stimulates Nonenzymic, α-Tocopherol-mediated Peroxidation of Cholesteryl Esters* , 1997, The Journal of Biological Chemistry.
[356] A. Lusis,et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins , 1990, Nature.
[357] G. Schmitz,et al. C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. , 1999, Circulation.
[358] J. Berliner,et al. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist. , 1997, Advances in experimental medicine and biology.
[359] W. Hsueh,et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. , 1997, The American journal of physiology.
[360] F. Liao,et al. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1 , 1995, The Journal of experimental medicine.
[361] J. Coucher,et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. , 1992, The American journal of pathology.
[362] E. Leonard,et al. Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.
[363] L. Marshall,et al. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation. , 1999, Advances in experimental medicine and biology.
[364] W. März,et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. , 1999, Circulation.
[365] K. Sakariassen,et al. Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis. , 1997, Thrombosis research.
[366] A. M. Lefer,et al. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. , 1996, Circulation research.
[367] J. Banchereau,et al. CD40‐CD40 ligand , 2000, Journal of leukocyte biology.
[368] J. Nadel,et al. An in vivo chemotaxis assay in the dog trachea: evidence for chemotactic activity of 8,15-diHETE. , 1988, Journal of applied physiology.
[369] R. Silverstein,et al. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[370] A. Eklund,et al. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. , 1994, Cellular immunology.
[371] S. Coughlin,et al. Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.
[372] S. Rankin,et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.
[373] B. Grabensee,et al. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[374] K. Ley,et al. Adhesion molecules and atherogenesis. , 2001, Acta physiologica Scandinavica.
[375] Tzong-Shyuan Lee,et al. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[376] T. Matsumura,et al. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[377] W. Muller. The role of PECAM‐1 (CD31) in leukocyte emigration: studies in vitro and in vivo , 1995, Journal of leukocyte biology.
[378] T. Akahoshi,et al. In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[379] C. Dinarello,et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. , 1993, Blood.
[380] P. Barnes,et al. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs. , 1993, European journal of pharmacology.
[381] K. Burnand,et al. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. , 1999, The American journal of pathology.
[382] C. Serhan,et al. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction , 1996, The Journal of experimental medicine.
[383] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[384] B. Seed,et al. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.
[385] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[386] C. Bruni,et al. Helicobacter pylori Up-regulates Cyclooxygenase-2 mRNA Expression and Prostaglandin E2 Synthesis in MKN 28 Gastric Mucosal Cells in Vitro * , 1998, The Journal of Biological Chemistry.
[387] D. Morel,et al. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.
[388] K. Preissner,et al. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[389] B. Østerud. Tissue factor expression in monocytes: in vitro compared to ex vivo. , 2000 .
[390] J. Miyazaki,et al. Role of cytosolic phospholipase A2 in allergic response and parturition , 1997, Nature.
[391] Robert A. Lewis,et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function , 1985 .
[392] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[393] D. Goeddel,et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES , 1990, Nature.
[394] J. Tischfield. A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals* , 1997, The Journal of Biological Chemistry.
[395] A. Daugherty,et al. Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E−/− Mice Through Release of Interferon-&ggr; , 2002, Circulation research.
[396] Yoon Lee,et al. Tumor Necrosis Factor Receptor Superfamily 14 Is Involved in Atherogenesis by Inducing Proinflammatory Cytokines and Matrix Metalloproteinases , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[397] T. Rajavashisth,et al. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL : involvement of nuclear factor-κB , 1995 .
[398] K. Matsumoto,et al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[399] M. Hamberg,et al. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[400] M. Murakami,et al. Secretory phospholipases A2. , 1995, Journal of lipid mediators and cell signalling.
[401] B. Descamps-Latscha,et al. Long-term dialysis and cellular immunity: a critical survey. , 1993, Kidney international. Supplement.
[402] N. Leitinger,et al. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets. , 1997, Thrombosis research.
[403] T. Schall,et al. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes , 1992, The Journal of experimental medicine.
[404] Endothelin-1 causes P-selectin-dependent leukocyte rolling and adhesion within rat mesenteric microvessels. , 1999, American journal of physiology. Heart and circulatory physiology.